Randomised clinical trial: a leucine‐metformin‐sildenafil combination (NS‐0200) vs placebo in patients with non‐alcoholic fatty liver disease
Alimentary Pharmacology & Therapeutics2018Vol. 47(12), pp. 1639–1651
Citations Over TimeTop 10% of 2018 papers
Naga Chalasani, Raj Vuppalanchi, Mary E. Rinella, Michael S. Middleton, Mohammad Shadab Siddiqui, A. Sidney Barritt, Orville Kolterman, Omar Flores, Cristina Alonso, Marta Iruarrizaga‐Lejarreta, Rubén Gil‐Redondo, Claude B. Sirlin, Michael B. Zemel
Abstract
These data support further evaluation of high-dose NS-0200 for treating NASH, especially in those with elevated ALT (NCT 02546609).
Related Papers
- → Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences(2018)251 cited
- A Rare Side Effect of Metformin: Metformin-Induced Hepatotoxicity(2007)
- → Metformin for Prevention of Type 2 Diabetes(2004)11 cited
- Advances in the study on metformin beyond its hypoglycemic effect(2013)
- 당뇨를 동반한 4기 대장암 환자에서 항암약물요법 반응 및 생존율에 대한 Metformin의 효과(2012)